Literature DB >> 21474709

TRIM40 promotes neddylation of IKKγ and is downregulated in gastrointestinal cancers.

Keita Noguchi1, Fumihiko Okumura, Norihiko Takahashi, Akihiko Kataoka, Toshiya Kamiyama, Satoru Todo, Shigetsugu Hatakeyama.   

Abstract

Gastrointestinal neoplasia seems to be a common consequence of chronic inflammation in the gastrointestinal epithelium. Nuclear factor-kappaB (NF-κB) is an important transcription factor for carcinogenesis in chronic inflammatory diseases and plays a key role in promoting inflammation-associated carcinoma in the gastrointestinal tract. Activation of NF-κB is regulated by several posttranslational modifications including phosphorylation, ubiquitination and neddylation. In this study, we showed that tripartite motif (TRIM) 40 is highly expressed in the gastrointestinal tract and that TRIM40 physically binds to Nedd8, which is conjugated to target proteins by neddylation. We also found that TRIM40 promotes the neddylation of inhibitor of nuclear factor kappaB kinase subunit gamma, which is a crucial regulator for NF-κB activation, and consequently causes inhibition of NF-κB activity, whereas a dominant-negative mutant of TRIM40 lacking the RING domain does not inhibit NF-κB activity. Knockdown of TRIM40 in the small intestinal epithelial cell line IEC-6 caused NF-κB activation followed by increased cell growth. In addition, we found that TRIM40 is highly expressed in normal gastrointestinal epithelia but that TRIM40 is downregulated in gastrointestinal carcinomas and chronic inflammatory lesions of the gastrointestinal tract. These findings suggest that TRIM40 inhibits NF-κB activity via neddylation of inhibitor of nuclear factor kappaB kinase subunit gamma and that TRIM40 prevents inflammation-associated carcinogenesis in the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21474709     DOI: 10.1093/carcin/bgr068

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  45 in total

1.  Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease?

Authors:  Caroline Jefferies; Claire Wynne; Rowan Higgs
Journal:  Nat Rev Immunol       Date:  2011-08-25       Impact factor: 53.106

2.  Atlas of human diseases influenced by genetic variants with extreme allele frequency differences.

Authors:  Arvis Sulovari; Yolanda H Chen; James J Hudziak; Dawei Li
Journal:  Hum Genet       Date:  2016-10-03       Impact factor: 4.132

Review 3.  Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy.

Authors:  Yongchao Zhao; Meredith A Morgan; Yi Sun
Journal:  Antioxid Redox Signal       Date:  2014-02-20       Impact factor: 8.401

4.  HDM2 Promotes NEDDylation of Hepatitis B Virus HBx To Enhance Its Stability and Function.

Authors:  Ningning Liu; Jinfang Zhang; Xiaohai Yang; Tong Jiao; Xin Zhao; Wenxia Li; Jianhua Zhu; Pu Yang; Jianping Jin; Jirun Peng; Zhiwei Li; Xin Ye
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

5.  TRIM proteins and cancer.

Authors:  Shigetsugu Hatakeyama
Journal:  Nat Rev Cancer       Date:  2011-10-07       Impact factor: 60.716

6.  A qualitative transcriptional signature for the early diagnosis of colorectal cancer.

Authors:  Qingzhou Guan; Qiuhong Zeng; Haidan Yan; Jiajing Xie; Jun Cheng; Lu Ao; Jun He; Wenyuan Zhao; Kui Chen; You Guo; Guoxian Guan; Zheng Guo
Journal:  Cancer Sci       Date:  2019-09-03       Impact factor: 6.716

7.  Gene expression in bovine rumen epithelium during weaning identifies molecular regulators of rumen development and growth.

Authors:  Erin E Connor; Ransom L Baldwin; Cong-jun Li; Robert W Li; Hoyoung Chung
Journal:  Funct Integr Genomics       Date:  2013-01-13       Impact factor: 3.410

8.  TRIM39 negatively regulates the NFκB-mediated signaling pathway through stabilization of Cactin.

Authors:  Masanobu Suzuki; Masashi Watanabe; Yuji Nakamaru; Dai Takagi; Hidehisa Takahashi; Satoshi Fukuda; Shigetsugu Hatakeyama
Journal:  Cell Mol Life Sci       Date:  2015-09-12       Impact factor: 9.261

Review 9.  Protein neddylation and its alterations in human cancers for targeted therapy.

Authors:  Lisha Zhou; Wenjuan Zhang; Yi Sun; Lijun Jia
Journal:  Cell Signal       Date:  2018-01-10       Impact factor: 4.315

Review 10.  TRIM Proteins in Inflammation: from Expression to Emerging Regulatory Mechanisms.

Authors:  Luting Yang; Haibin Xia
Journal:  Inflammation       Date:  2021-01-07       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.